The Scientist

» clinical trials and immunology

Most Recent

image: Filippos Porichis: Immunoregulator

Filippos Porichis: Immunoregulator

By | May 1, 2015

Principal Investigator, Ragon Institute of MGH, MIT, and Harvard. Age: 33

0 Comments

image: Heart Strings

Heart Strings

By | May 1, 2015

An animated primer on the harvesting, growth, and administration of cardiac cells to heart attack patients

0 Comments

image: Llamas as Lab Rats

Llamas as Lab Rats

By | May 1, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

0 Comments

image: Looking for Latent HIV

Looking for Latent HIV

By | May 1, 2015

Sequencing HIV integration sites suggests that clonally expanded T-cell populations may not be the main source of latent virus.

0 Comments

image: Soluble Signal

Soluble Signal

By | May 1, 2015

An immune protein previously thought to mark inactive T cells has a free-floating form that correlates with HIV disease progression.

0 Comments

image: Defeating the Virus

Defeating the Virus

By | May 1, 2015

Recent discoveries are spurring a renaissance in HIV vaccine research and development.

0 Comments

image: Hearts on Trial

Hearts on Trial

By | May 1, 2015

As researchers conduct the most rigorous human trials of cardiac cell therapies yet attempted, a clear picture of whether these treatments actually work is imminent.

2 Comments

image: Eye Stem Cell Therapy Moves Ahead

Eye Stem Cell Therapy Moves Ahead

By | April 30, 2015

Researchers inject retinal support cells derived from human embryonic stem cells into the eyes of four men with macular degeneration, bolstering evidence of the experimental treatment’s safety.

4 Comments

image: FDA Calls for Data on ALS Drug

FDA Calls for Data on ALS Drug

By | April 21, 2015

In the midst of a debate about an experimental drug’s early approval, the US Food and Drug Administration requests that full trial results be released.

1 Comment

image: Study: Aspirin Reduces Cancer Risk

Study: Aspirin Reduces Cancer Risk

By | April 20, 2015

The largest and longest study of long-term, regular aspirin use finds that the drug may lead to a modestly reduced risk for some types of gastrointestinal cancers.

0 Comments

Popular Now

  1. Trump’s Proposed Budget Would Cut Science Funding
  2. Unstructured Proteins Help Tardigrades Survive Desiccation
  3. Science Advocates Decry Trump’s Proposed Budget
  4. Women Lose Vision After Stem Cell Treatment
Business Birmingham